- Patent Title: Predicting response to anti-vascular endothelial growth factor therapy with computer-extracted morphology and spatial arrangement features of leakage patterns on baseline fluorescein angiography in diabetic macular edema
-
Application No.: US16415833Application Date: 2019-05-17
-
Publication No.: US10943348B2Publication Date: 2021-03-09
- Inventor: Anant Madabhushi , Prateek Prasanna , Justis Ehlers , Sunil Srivastava
- Applicant: Case Western Reserve University , The Cleveland Clinic Foundation
- Applicant Address: US OH Cleveland; US OH Cleveland
- Assignee: Case Western Reserve University,The Cleveland Clinic Foundation
- Current Assignee: Case Western Reserve University,The Cleveland Clinic Foundation
- Current Assignee Address: US OH Cleveland; US OH Cleveland
- Agency: Eschweiler & Potashnik, LLC
- Main IPC: G06K9/46
- IPC: G06K9/46 ; G06T7/00 ; G06K9/62 ; G06T7/32 ; G06T7/11 ; G06T5/50 ; G06T5/20 ; A61B3/12 ; A61B5/00

Abstract:
Embodiments facilitate prediction of anti-vascular endothelial growth (anti-VEGF) therapy response in DME patients. A first set of embodiments discussed herein relates to training of a machine learning classifier to determine a prediction for response to anti-VEGF therapy based on a set of graph-network features and a set of morphological features generated based on FA images of tissue demonstrating DME. A second set of embodiments discussed herein relates to determination of a prediction of response to anti-VEGF therapy for a DME patient (e.g., non-rebounder vs. rebounder, response vs. non-response) based on a set of graph-network features and a set of morphological features generated based on FA imagery of the patient.
Public/Granted literature
Information query